← Back to Search

WiseApp for HIV

N/A
Recruiting
Led By Rebecca Schnall, PhD, MPH
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Having been diagnosed with HIV ≥6 months ago
Aged ≥18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 month follow up, 6 month follow up, and 12 month follow up
Awards & highlights

Summary

This trial will adapt a mobile app and a smart pill dispenser for Spanish-speaking people living with HIV in NYC and the Dominican Republic. They will assess the efficacy and sustainability of the app, as well as identify barriers to its widespread use among Spanish speakers.

Who is the study for?
This trial is for Spanish-speaking adults living with HIV in NYC or La Romana, DR. Participants must have been diagnosed at least 6 months ago, have an HIV-1 RNA level >50 copies/mL, own a smartphone, and be willing to join any part of the study. It's not for those in long-term care facilities, planning to move soon, from the same household as another participant, terminally ill or with certain cognitive impairments.
What is being tested?
The WiseApp mobile app and smart pill dispenser are being tested over a year-long randomized controlled trial among Spanish speakers with HIV. The goal is to adapt these technologies for better engagement and clinical outcomes by understanding barriers specific to this group.
What are the potential side effects?
Since WiseApp is a technology-based intervention without direct medical treatments or drugs involved, there may not be traditional side effects; however participants might experience privacy concerns or stress related to using new technology.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I was diagnosed with HIV more than 6 months ago.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 month follow up, 6 month follow up, and 12 month follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 month follow up, 6 month follow up, and 12 month follow up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in self-reported ART adherence
Secondary study objectives
Change In Participant's Self-reported Health-related Quality of Life Score
Change in Viral Load
Change in cluster of differentiation 4 (CD4) Count

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
WiseApp that delivers medication adherence reminders
Group II: ControlActive Control1 Intervention
The control includes standard health services offered at each site (e.g., mental health services, case-management, referral to clinical care) and a brief adherence educational session.

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,471 Previous Clinical Trials
2,536,102 Total Patients Enrolled
Clínica de Familia La Romana, Dominican RepublicUNKNOWN
Rebecca Schnall, PhD, MPHPrincipal InvestigatorColumbia University
3 Previous Clinical Trials
560 Total Patients Enrolled

Media Library

WiseApp Clinical Trial Eligibility Overview. Trial Name: NCT05398185 — N/A
Human Immunodeficiency Virus Infection Research Study Groups: Intervention, Control
Human Immunodeficiency Virus Infection Clinical Trial 2023: WiseApp Highlights & Side Effects. Trial Name: NCT05398185 — N/A
WiseApp 2023 Treatment Timeline for Medical Study. Trial Name: NCT05398185 — N/A
~109 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top